BackACRO Biomedical , Ltd. Overview

ACRO Biomedical , Ltd. Common Stock

Track ACRO Biomedical , Ltd.'s common stock ($710M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$712.18M
↑ 16.34% YoYΔ $100.00M vs prior year quarter

Peer trimmed avg / median

Loading

ACRO Biomedical , Ltd. Common Stock History

Loading

ACRO Biomedical , Ltd. vs. peers: Common Stock Comparison

Loading

ACRO Biomedical , Ltd. Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

ACRO Biomedical , Ltd. (6748.TWO) FAQ

ACRO Biomedical , Ltd. posts a common stock of $710M as of June 2026. That compares with $610M in the prior-year period — up 16.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, ACRO Biomedical , Ltd.'s common stock was $610M. The latest reading is $710M — a 16.3% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Common Stock is one piece of ACRO Biomedical , Ltd.'s financial statement story. At $710M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 6748.TWO's common stock usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; ACRO Biomedical , Ltd.'s other metric pages and overview cover the third.